- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/71 - ReceptorsCell surface antigensCell surface determinants for growth factorsReceptorsCell surface antigensCell surface determinants for growth regulators
Patent holdings for IPC class C07K 14/71
Total number of patents in this class: 2226
10-year publication summary
|
134
|
140
|
153
|
144
|
205
|
220
|
170
|
156
|
169
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Acceleron Pharma Inc. | 351 |
142 |
| Regeneron Pharmaceuticals, Inc. | 4455 |
133 |
| Amgen Inc. | 4278 |
36 |
| The Regents of the University of California | 20315 |
34 |
| Immatics Biotechnologies GmbH | 1150 |
31 |
| Keros Therapeutics, Inc. | 70 |
28 |
| The Trustees of the University of Pennsylvania | 4382 |
24 |
| Board of Regents, The University of Texas System | 5959 |
23 |
| The Board of Trustees of the Leland Stanford Junior University | 6552 |
21 |
| Genentech, Inc. | 4011 |
20 |
| City of Hope | 1009 |
20 |
| Immunitybio, Inc. | 484 |
20 |
| Precigen Inc | 103 |
19 |
| Genzyme Corporation | 1324 |
18 |
| The Johns Hopkins University | 5764 |
17 |
| Biocon Limited | 222 |
17 |
| Seattle Children's Hospital | 85 |
16 |
| Novartis AG | 10511 |
15 |
| Merck Patent GmbH | 5735 |
15 |
| Foundation Medicine, Inc. | 379 |
15 |
| Other owners | 1562 |